Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Doxylamine succinate; pyridoxine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for doxylamine succinate; pyridoxine hydrochloride and what is the scope of doxylamine succinate; pyridoxine hydrochloride freedom to operate?

Doxylamine succinate; pyridoxine hydrochloride
is the generic ingredient in four branded drugs marketed by Actavis Labs Fl Inc, Duchesnay, and Sanofi Aventis Us, and is included in four NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Doxylamine succinate; pyridoxine hydrochloride has sixty patent family members in thirty-six countries.

There are thirteen drug master file entries for doxylamine succinate; pyridoxine hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: doxylamine succinate; pyridoxine hydrochloride

Drug Master File Entries: see list13
Suppliers / Packagers: see list1
Clinical Trials: see list1,047
Drug Prices:see low prices
DailyMed Link:doxylamine succinate; pyridoxine hydrochloride at DailyMed

Pharmacology for Ingredient: doxylamine succinate; pyridoxine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL209661-001Nov 7, 2016RXYesYes► Subscribe► Subscribe
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL021876-001Apr 8, 2013ABRXYesYes7,560,122► SubscribeY ► Subscribe
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL021876-001Apr 8, 2013ABRXYesYes6,340,695► SubscribeY ► Subscribe
Actavis Labs Fl Inc
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL205811-001Aug 19, 2016ABRXNoNo► Subscribe► Subscribe
Sanofi Aventis Us
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL010598-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus